AMAG Pharma (AMAG) Shares Rise as Ladenburg Upgrades to Buy
Tweet
Share
E-mailGet Alerts AMAG Hot Sheet
Price: $13.75 --0%
Rating Summary:
8 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
8 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Ladenburg Thalmann's Juan Sanchez upgraded shares of AMAG Pharmaceuticals (NASDAQ: AMAG) from Neutral to Buy in an intraday research note Monday. The analyst maintains an $18 price target.
The stock seems to be reacting to the mid-day upgrade: shares are now up 3.8 percent to $14.08.
For more ratings news on AMAG Pharmaceuticals click here and for the rating history of AMAG Pharmaceuticals click here.
The stock seems to be reacting to the mid-day upgrade: shares are now up 3.8 percent to $14.08.
For more ratings news on AMAG Pharmaceuticals click here and for the rating history of AMAG Pharmaceuticals click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Upgrades Apollo Tyres (APTY:IN) to Buy
- Freedom Broker Upgrades Walmart (WMT) to Buy
- Freedom Broker Upgrades Taylor Devices, Inc. (TAYD) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
Ladenburg Thalmann Financial ServicesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
